These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27370228)

  • 21. Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
    Gilgun-Sherki Y; Panet H; Melamed E; Offen D
    Brain Res; 2003 Nov; 989(2):196-204. PubMed ID: 14556941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinematic gait parameters are highly sensitive measures of motor deficits and spinal cord injury in mice subjected to experimental autoimmune encephalomyelitis.
    Fiander MD; Stifani N; Nichols M; Akay T; Robertson GS
    Behav Brain Res; 2017 Jan; 317():95-108. PubMed ID: 27639322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroinflammation and B-Cell Phenotypes in Cervical and Lumbosacral Regions of the Spinal Cord in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin.
    Kummari E; Nichols JM; Yang EJ; Kaplan BLF
    Neuroimmunomodulation; 2019; 26(4):198-207. PubMed ID: 31454809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
    Makar TK; Gerzanich V; Nimmagadda VK; Jain R; Lam K; Mubariz F; Trisler D; Ivanova S; Woo SK; Kwon MS; Bryan J; Bever CT; Simard JM
    J Neuroinflammation; 2015 Nov; 12():210. PubMed ID: 26581714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
    Levy Barazany H; Barazany D; Puckett L; Blanga-Kanfi S; Borenstein-Auerbach N; Yang K; Peron JP; Weiner HL; Frenkel D
    Exp Neurol; 2014 May; 255():63-70. PubMed ID: 24552689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
    Pryor WM; Freeman KG; Larson RD; Edwards GL; White LJ
    J Neurosci Res; 2015 May; 93(5):697-706. PubMed ID: 25510644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA; Welsh ME; Carter DE; Karlik SJ
    J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice.
    Lev N; Barhum Y; Melamed E; Offen D
    Neurosci Lett; 2004 Apr; 359(3):139-42. PubMed ID: 15050683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination.
    Une H; Yamasaki R; Nagata S; Yamaguchi H; Nakamuta Y; Indiasari UC; Cui Y; Shinoda K; Masaki K; Götz M; Kira JI
    J Neuroinflammation; 2021 Jun; 18(1):126. PubMed ID: 34090477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis.
    Casamassa A; La Rocca C; Sokolow S; Herchuelz A; Matarese G; Annunziato L; Boscia F
    Glia; 2016 Jul; 64(7):1124-37. PubMed ID: 27120265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
    Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
    J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis.
    Sun Y; Chen H; Dai J; Zou H; Gao M; Wu H; Ming B; Lai L; Xiao Y; Xiong P; Xu Y; Gong F; Zheng F
    J Neuroimmunol; 2015 Mar; 280():29-35. PubMed ID: 25773152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acylated and deacylated quillaja saponin-21 adjuvants have opposite roles when utilized for immunization of C57BL/6 mice model with MOG
    Heidari AR; Boroumand-Noughabi S; Nosratabadi R; Lavi Arab F; Tabasi N; Rastin M; Mahmoudi M
    Mult Scler Relat Disord; 2019 Apr; 29():68-82. PubMed ID: 30685444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia.
    Bannerman P; Hahn A; Soulika A; Gallo V; Pleasure D
    Glia; 2007 Jan; 55(1):57-64. PubMed ID: 17009237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-invasive visual evoked potentials to assess optic nerve involvement in the dark agouti rat model of experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein.
    Castoldi V; Marenna S; d'Isa R; Huang SC; De Battista D; Chirizzi C; Chaabane L; Kumar D; Boschert U; Comi G; Leocani L
    Brain Pathol; 2020 Jan; 30(1):137-150. PubMed ID: 31267597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice.
    Kohs TCL; Fallon ME; Oseas EC; Healy LD; Tucker EI; Gailani D; McCarty OJT; Vandenbark AA; Offner H; Verbout NG
    Metab Brain Dis; 2023 Oct; 38(7):2383-2391. PubMed ID: 37341855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Lima A; Roig P; De Nicola AF
    J Steroid Biochem Mol Biol; 2007; 107(3-5):228-37. PubMed ID: 17692515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.